Hyderabad-based pharma player Laurus Labs has received a licence from the Defence Research & Development Organisation (DRDO) for manufacturing and marketing Covid-19 drug 2-Deoxy-D-Glucose (2-DG) in India. The licence to Laurus Labs has been granted by DRDO as part of efforts to make the drug affordable and accessible to patients.
DRDO had recently invited expression of interest (EoI) from other pharma companies for manufacturing this drug and had said it would grant licences to 15 companies on a first-come, first-served basis. Meanwhile, the Council of Scientific & Industrial Research institution Indian Institute of Chemical Technology (CSIR-IICT) has been licencing the know-how for 2-DG synthesis to other companies, including Lee Pharma, Suven Pharma, Anthem Biosciences and Nosch Labs.
The 12th-century Jagannath Temple in Puri, the Shree Jagannath Temple Administration (SJTA) has attained trademark…
India has had an abundance of legendary players in weight lifting like Mirabai Chanu, Karnam…
The Mahatma Jyotirao Phule Jan Arogya Yojana (MJPJAY) is a premium health insurance initiative started…
As work are underway for the 2027 Haridwar Kumbh Mela, the Uttarakhand Forest Department has…
The Majhi Kanya Bhagyashree Scheme is a important government initiative run by the Maharashtra Government…
Bhargavastra is a homegrown anti-swarm drone system that has been engineered to neutralize enemy drones…